Money Thrill : Indeed, time to follow and buy? the results or better statistics of research are not really relevant and are open to interpretation. I research it and write an article about it later. Price could go up too much People only read it halfway ...

Money Thrill : Good drop is an Good buy now. Analysts do not know anything about this company and others medicines? Also about statistics... never believe them ? Shall explain later,  first buy

Ultratech OP Money Thrill : well i don't know anything about them either so idk if it's a good buy now or if should wait

Money Thrill : I suppose it is now the moment, the next days to follow and buy. I have many articles of it, investments,  new drugs etc ...  And about the statistics?  Here better information.  
A pipeline, one that built on the previous blockbusters. But the latest research results were disappointing. A test with some 3,400 patients led to an average weight loss of 22.7% after 68 weeks, which was less than the 25% the company had expected. It scored "only as well" as Zepbound from competitor Eli Lilly, which is already on the market.
Nevertheless, Novo Nordisk will ask the regulators of the pharmaceutical industry to allow the drug to be commercialized. In doing so, they also point to a number of research limitations. Fewer than six out of ten obese patients are said to have used the highest permitted dose.
Investors reacted negatively and immediately pressed the sell button. Yesterday, the share fell almost 21% to 589.20 Danish krone (79 euros). In trading, it had briefly lost almost 30%.

Ultratech OP Money Thrill : I'm saying for others who may be looking at the leaveraged etf i posted. medical/bio stuff isn't my thing

Money Thrill : All statistics are subject to interpretation...  limitations? So,  never 100% reliable !!! But it is better so, if they wants to regulate it in US ? Lesser than Eli Lilly    ".... reading between the lines .... "

Ben the Oracle : Selling NVO is a big mistake. Watch as it fully rebound starting tomorrow . You will regret selling

hardeep dhaliwal : Based on Company’s financial Statements it will fly….